Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pfitzner

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Molecular Plant Pathology|December 2, 2010
NONEXPRESSOR OF PATHOGENESIS-RELATED PROTEINS1 (NPR1) and some NPR1-related proteins are sensitive to salicylic acidFelix Maier, Sylvia Zwicker, Angela Hückelhoven, et al.
International Journal of Cancer|August 27, 2014
Glutamate enrichment as new diagnostic opportunity in breast cancerJan Budczies, Berit M Pfitzner, Balazs Györffy, et al.
Scientific Reports|November 15, 2019
Bioactive coating of zirconia toughened alumina ceramic implants improves cancellous osseointegrationAnne-Marie Pobloth, Max J Mersiowsky, Luisa Kliemt, et al.
Virchows Archiv : an International Journal of Pathology|September 15, 2014
Preanalytical variables and performance of diagnostic RNA-based gene expression analysis in breast cancerChristopher Poremba, Jennifer Uhlendorff, Berit M Pfitzner, et al.
Cell Death & Disease|February 19, 2026
mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR<sup>+</sup>/HER2<sup>-</sup> breast cancerLuise von Wichert, Alina Stroh, Marie Witt, et al.
Cancer Gene Therapy|September 12, 2015
A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevanceM Dietel, K Jöhrens, M V Laffert, et al.
Breast Cancer Research and Treatment|November 28, 2017
Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancerS L Villegas, S Darb-Esfahani, G von Minckwitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2016
Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast CancerBarbara Ingold Heppner, Michael Untch, Carsten Denkert, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 23, 2017
Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 yearsBerit M Pfitzner, Bianca Lederer, Judith Lindner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2014
Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapyJ L Lindner, S Loibl, C Denkert, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Molecular Plant Pathology|December 2, 2010
NONEXPRESSOR OF PATHOGENESIS-RELATED PROTEINS1 (NPR1) and some NPR1-related proteins are sensitive to salicylic acidFelix Maier, Sylvia Zwicker, Angela Hückelhoven, et al.
International Journal of Cancer|August 27, 2014
Glutamate enrichment as new diagnostic opportunity in breast cancerJan Budczies, Berit M Pfitzner, Balazs Györffy, et al.
Scientific Reports|November 15, 2019
Bioactive coating of zirconia toughened alumina ceramic implants improves cancellous osseointegrationAnne-Marie Pobloth, Max J Mersiowsky, Luisa Kliemt, et al.
Virchows Archiv : an International Journal of Pathology|September 15, 2014
Preanalytical variables and performance of diagnostic RNA-based gene expression analysis in breast cancerChristopher Poremba, Jennifer Uhlendorff, Berit M Pfitzner, et al.
Cell Death & Disease|February 19, 2026
mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR<sup>+</sup>/HER2<sup>-</sup> breast cancerLuise von Wichert, Alina Stroh, Marie Witt, et al.
Cancer Gene Therapy|September 12, 2015
A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevanceM Dietel, K Jöhrens, M V Laffert, et al.
Breast Cancer Research and Treatment|November 28, 2017
Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancerS L Villegas, S Darb-Esfahani, G von Minckwitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2016
Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast CancerBarbara Ingold Heppner, Michael Untch, Carsten Denkert, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 23, 2017
Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 yearsBerit M Pfitzner, Bianca Lederer, Judith Lindner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2014
Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapyJ L Lindner, S Loibl, C Denkert, et al.
Pageof 4